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Abstract: Background: The multidimensional assessment of frailty allows stratifying it into degrees;
however, there is still heterogeneity in the characteristics of people in each stratum. The aim of this
study was to identify frailty profiles of older people users of a home-based primary care service.
Methods: We carried out an observational study from January 2018 to January 2021. Participants were
all people cared for a home-based primary care service. We performed a cluster analysis by applying a
k-means clustering technique. Cluster labeling was determined with the 22 variables of the Frail-VIG
index, age, and sex. We computed multiple indexes to assess the optimal number of clusters, and this
was selected based on a clinical assessment of the best options. Results: Four hundred and twelve
participants were clustered into six profiles. Three of these profiles corresponded to a moderate frailty
degree, two to a severe frailty degree and one to a mild frailty degree. In addition, almost 75% of the
participants were clustered into three profiles which corresponded to mild and moderate degree of
frailty. Conclusions: Different profiles were found within the same degree of frailty. Knowledge of
these profiles can be useful in developing strategies tailored to these differentiated care needs.
Keywords: care dependence; cluster analysis; frailty; home care; multimorbidity; primary health care
1. Introduction
The aging of the world’s population is contributing to an increase in the number of
people with multimorbidity and complex care needs; as a result, the condition of frailty
is receiving greater international interest [1]. Frailty is characterized by a decline in the
functioning of multiple physiological systems accompanied by an increased vulnerability
to stressors [2]. Moreover, frailty determines a reduction in functional reserve and a higher
risk of adverse outcomes such as increased mortality, disability and use of healthcare
resources [3–5]. It is also age-related, progressive, dynamic and potentially modifiable–and,
therefore, preventable [6,7]. Furthermore, the introduction of the concept of frailty in
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clinical practice allows the identification of complex care needs by differentiating between
chronological and biological age.
Today, the definition of frailty remains questioned, but according to the World Health
Organisation, it is defined as “a progressive age-related decline in physiological systems
that results in decreased reserves of intrinsic capacity, which confers extreme vulnerability
to stressors and increases the risk of a range of adverse health outcomes” [8]. The main
measurement approaches are the Fried’s frailty phenotype [9] and Rockwood and Mitnit-
ski’s accumulation of deficits model [10]. The frailty phenotype is based on the presence
of three or more of the following criteria: involuntary weight loss, exhaustion, slow gait
speed, poor handgrip strength, and sedentary behaviour. Its use may be more suitable
for the identification of non-disabled older people at risk of adverse health outcomes [11].
Regarding the accumulation of deficits model, allows an understanding of the concept
through the complex interaction of physical, psychological and social factors that lead to
frailty, expressed as a frailty index (FI). This FI is a ratio of potential age-related deficits
that include disease, disability and geriatric syndromes [10]. The FI may be a more useful
tool than the frailty phenotype to establish the effectiveness of any intervention and to
describe the health status trajectories over time [11,12]. A large number of FIs have been
developed based on this model, among which we highlight the Frail-VIG index. It has a
multidimensional approach and is based on a comprehensive geriatric assessment (VIG is
the Spanish/Catalan abbreviation for ‘comprehensive geriatric assessment). The Frail-VIG
index fits well with the biopsychosocial model of primary care and allows stratification
of people into degrees of frailty, making it easier to set tailored therapeutic goals and
therapeutic intensity [13].
However, we still found heterogeneity among the characteristics of the people classi-
fied under each degree of frailty. Therefore, identifying different profiles of people would
contribute to gaining additional knowledge about specific characteristics, and consequently,
further facilitate personalization of the care plan. A number of previous studies have ex-
plored this approach with a comprehensive assessment approach among older people
living in the community. Lafortune et al. identify four profiles, incorporating the physical
and cognitive dimensions [14]. Armstrong et al. identify seven relatively homogeneous
profiles among people receiving rehabilitation at home, which differ in terms of character-
istics such as age, sex, cognition and functional impairment [15]. In a more recent study,
Looman et al. identify six clusters around physical, cognitive and social functioning [16].
Other authors explore patterns based on multimorbidity [17,18], which is defined as the
presence of two of more chronic diseases or conditions [19].
However, profiles based solely on morbidity do not capture other aspects of people’s
complex needs when considering at-home care. In this regard, multidimensional FIs
include interrelated concepts of interest such as morbidity, frailty and dependence. On the
other hand, morbidity can be considered as an antecedent of frailty and dependence as a
consequence of it [20,21]. Dependence is defined as a person’s lack of ability to perform
basic activities needed for daily living as a result of a decrease in functional capacity [8]. It
is important to identify these concepts correctly [22], because whilst they are related, their
management is different and can confuse interventions designed to prevent and mitigate
frailty. In addition, no research has been found that analyzed people’s profiles from a
broad perspective, incorporating different domains of frailty (biological, psychological, and
social), together with multimorbidity and dependence. Finally, people living with frailty
risk experiencing a decline in their quality of life. Previous research shows the negative
association between frailty, multimorbidity and dependence with respect to quality of
life [23–25] Therefore, interventions aimed at decreasing frailty could have the added
benefit of improving quality of life.
For all these reasons we decided to carry out this study, the aim of which was to
identify frailty profiles of older people users of a home-based primary care service, from
a comprehensive perspective, using the Frail-VIG index which integrates the concepts of
frailty (physical, cognitive and social), multimorbidity and dependence.
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2. Materials and Methods
2.1. Study Design, Scope, Period and Subjects
We carried out an observational study and cluster analysis in two health care areas
of the Institut Català de la Salut (Catalan Health Institute) in Barcelona, Spain, that serve
a population of 51,121 users. This is a population with a medium-high socioeconomic
level and a lower percentage of immigration than the mean for Catalonia (9.8% and 8.8%
respectively, compared to 14.6% for Catalonia) and a high level of over-aging (26.8% and
28.8% of people over 65 respectively, compared to the Catalan mean of 19.4%) [26]. The
study period was from January 2018 to January 2021.
Participants were all people included to under the home-care program during 2018.
This program included all those who could not go to the health center for reasons of
health, physical condition, or their social situation or environment. Two general practi-
tioners and four community nurses manage this program, which was also supported by a
social worker and a nurse case manager. All variables were assessed at baseline, except
mortality, which was evaluated at 12 and 24 months after baseline.
2.2. Measurement Variables and Instruments
Frailty was measured using the Frail-VIG index. Published in 2017 by Amblàs- Novel-
las et al. [27], this FI based on the comprehensive geriatric assessment, consists of 22 trigger
questions that are used to assess 25 deficits from eight assessment domains (functional,
nutritional, cognitive, emotional, social, geriatric syndromes, severe symptoms and chronic
diseases). The final score, which is obtained by dividing the accumulated deficits by
the total potential accumulable deficits, range from 0 to 1 (with the submaximal limit
in the clinical practice being close to 0.7). There is an Excel calculator available at:
https://en.c3rg.com/index-fragil-vig (accessed on 11 May 2021). It enables people to
be grouped according to degrees of frailty: non-frailty (<0.20), mild frailty (0.20–0.35),
moderate frailty (0.36–0.50) and severe frailty (>0.50). The Frail-VIG index has shown a
high prognostic value for 12-month mortality (value under the ROC curve of 0.9, 95% CI
0.88–0.92) [13,27].
For the cluster analysis, the variables were grouped as: sociodemographic (age, sex),
diseases (cardiac, respiratory, renal, neurological, hepatic/digestive, cancer), symptoms
(pain, dyspnoea), physical frailty (nutrition, falls, ulcers, dysphagia), psychological frailty
(delirium, cognitive impairment, depression, anxiety), social vulnerability (the person
lives alone or the family has limitations or difficulty in offering support, conflictive family
relationship, inadequate hygiene conditions, inadequate housing, and lack of economic
resources), and functional dependence for activities of daily living (ADLs) and instrumental
activities of daily living (IADLs)
As a covariable, the perception of quality of life was measured by means of the EQ-5D-
3L index, using the reference values for the Spanish population [28]. We also determined
whether or not all participants had died at 12 and 24 months after the baseline assessment
date, by reviewing primary care electronic health records, which systematically include the
date of death.
2.3. Data Collection and Sources of Information
Community nurses from the home-care service performed a comprehensive geriatric
assessment as part of their usual practice. They also administered by interview the two
measurement instruments: the Frail-VIG index and the EQ-5D-3L index. The research team
held a preliminary consensus meeting with these nurses to unify criteria for collecting
the data from the aforementioned instruments, and a pilot test was carried out with
20 participants to identify potential problems and introduce strategies for improvement.
After the pilot, no changes in the procedure were necessary, and an instruction manual was
written to ensure homogeneous data collection.
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For the assessment of mortality at 12 and 24 months after the baseline assessment, we
reviewed electronic health records, which include up-to-date information on date of death,
regardless of the place where the death occurred.
2.4. Study Size
No sampling strategy was used in this study. All the older people users of the
home-based primary care service were included. In Spain, access to primary care is
guaranteed by law and home care is part of the primary care service portfolio [29]. There
is a comprehensive, multidisciplinary home care program; the study population was
identified from the patient lists for this population-based care program.
2.5. Data Analysis
Categorical variables were expressed as frequencies and percentages and continuous
variables as mean and standard deviation. Differences between clusters for descriptive
variables were evaluated using the chi-square test, ANOVA and Kruskal–Wallis based on
application conditions.
The cluster analysis was performed by applying the k-means hard clustering technique
to the dataset. Prior to the clustering, a manual selection of variables was done to avoid
overestimation of some data, and only the 22 variables of the frailty index, age and sex were
used to determine the cluster labeling. The criterion for selecting these variables was to
avoid duplicity of variables with similar clinical meaning. After grouping the individuals
into different clusters with these features, all variables were used to characterize the clusters.
PCAmix compression technique was used to reduce dimensionality of the data, noise
and deal efficiently with both dichotomous and continuous variables. Using this technique,
principal component analysis (PCA) was applied to the continuous age variable and
multiple correspondence analysis (MCA) to the dichotomous variables. According to
Kaiser criterion, only the most significant 13 transformed dimensions were retained to feed
the k-means clustering.
To assess the optimal number of clusters (k), Calinski-Harabasz, Xie-Beni and Silhou-
ette indexes were computed from the average of 100 different realizations for each possible
number from two to 20 [30]. To mitigate the negative effects of the random nature of the
clustering, a clusterboot technique was used to select the most stable cluster from 100 dif-
ferent realizations. The Calinski index did not reveal clear evidence for any clusters, while
Xie-beni and Silhouette gave better results for groups of three, six and nine clusters. Finally,
the determination of the optimal number of clusters was defined based on the principle of
parsimony and the potential clinical value of these three best options mentioned above. A
cluster was considered clinically valuable when it facilitated more tailored care (targeted
interventions) for frail people.
R version 3.6.3 software (Vienna, Austria) was used to preprocess the data and to
apply the clustering and IBM SPSS Statistic version 24 (Armonk, NY, USA) to characterize
the different obtained profiles.
2.6. Ethical Aspects
Informed consent was requested from the participants after they had been given oral
and written information about the aims of the study. The study complies with Spanish
regulations regarding the protection of personal data and was approved by the IDIAP’s
Clinical Research Ethics Committee–registration number P17/150.
3. Results
A total of 412 people participated in the study, mostly women (68.4%), with a mean age
of 88 (SD 8.1). Table 1 shows the characteristics of the participants in the total population.
31.3% of cases had three or more target organ diseases–the most prevalent being heart
disease (60.2%) and chronic kidney failure (50.0%). More than 60% of participants reported
significant functional dependence for ADLs and IADLs. Approximately half had some
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cognitive impairment, 51.5% showed social vulnerability and 17.0% lived alone. Quality
of life was negatively correlated with the degree of frailty. We described this finding in
more detail in a recent publication [31]. Overall mortality of the population at one year
was 31.1% and 46.1% at two years, with significant differences between the six profiles
identified (Table 1).
Table 1. Characteristics of participants in each of the six profiles identified through cluster analysis. Values are absolute
frequencies (percentages) unless stated otherwise.















Age Years, mean (SD) 88.0 (8.1) 87.7 (0.7) 83.8 (6.8) 86.1 (0.8) 92.7 (0.6) 87.9 (0.9) 84.4 (1.7) <0.001
Sex
Men 130 (31.6) 25 (23.6) 2 (50.0) 44 (43.6) 14 (15.2) 35 (53.8) 10 (22.7)
<0.001Women 282 (68.4) 81 (76.4) 2 (50.0) 57 (56.4) 78 (84.8) 30 (46.2) 34 (77.3)
Chronic Diseases
Cancer (active) 40 (9.7) 4 (3.8) 4 (100.0) 10 (9.9) 9 (9.8) 12 (18.5) 1 (2.3) 0.009
Respiratory 116 (28.2) 29 (27.4) 3 (75.0) 48 (47.5) 7 (7.6) 20 (30.8) 9 (20.5) <0.001
Cardiac 248 (60.2) 59 (55.7) 0 (0.0) 85 (84.2) 37 (40.2) 51 (78.5) 16 (36.4) <0.001
Neurological 151 (36.7) 17 (16.0) 1 (25.0) 48 (47.5) 22 (23.9) 40 (61.5) 23 (52.3) <0.001
Digestive 39 (9.5) 16 (15.1) 0 (0) 7 (6.9) 6 (6.5) 6 (9.2) 4 (9.1) 0.234
Renal (GFR < 60) 206 (50.0) 56 (52.8) 1 (25.0) 56 (55.4) 57 (62.0) 28 (43.1) 8 (18.2) <0.001
≥3 target organ diseases 129 (31.3) 30 (28.3) 1 (25.0) 51 (50.5) 15 (16.3) 30 (46.2) 2 (4.5) <0.001
Advanced Chronic
Disease 32 (7.8) 3 (2.8) 4 (100) 18 (17.8) 1 (1.1) 5 (7.7) 1 (2.3) <0.001
Severe Symptoms Pain 87 (21.1) 26 (24.5) 1 (25.0) 34 (33.7) 20 (21.7) 6 (9.2) 0 (0.0) <0.001
Dyspnea 19 (4.6) 4 (3.8) 0 (0.0) 14 (13.9) 0 (0.0) 0 (0.0) 1 (2.3) NA
Geriatric syndromes
Delirium 119 (28.9) 4 (3.8) 1 (25.0) 6 (5.9) 43 (46.7) 37 (56.9) 28 (63.6) <0.001
Falls 112 (27.2) 27 (25.5) 1 (25.0) 21 (20.8) 33 (35.9) 24 (36.9) 6 (13.6) 0.012
Ulcers 85 (20.6) 10 (9.4) 2 (50.0) 13 (12.9) 21 (22.8) 24 (36.9) 15 (34.1) <0.001
Dysphagia 75 (18.2) 0 (0.0) 1 (25.0) 11 (10.9) 1 (1.1) 29 (44.6) 33 (75.0) <0.001
Incontinence 295 (71.6) 45 (42.5) 4 (100) 70 (69.3) 79 (85.9) 54 (83.1) 43 (97.7) <0.001
Polypharmacy (≥5 drugs) 365 (88.6) 92 (86.8) 4 (100.0) 100 (99.0) 74 (80.4) 60 (92.3) 35 (79.5) <0.001
≥3 geriatric syndromes 87 (21.1) 3 (2.8) 1 (25.0) 6 (5.9) 20 (21.7) 33 (50.8) 24 (54.5) <0.001
Malnutrition Weight loss≥5% in the last 6 months 70 (17.0) 18 (17.0) 2 (50.0) 11 (10.9) 10 (10.9) 22 (33.8) 7 (15.9) 0.001
Cognitive impairment
Cognitive impairment 214 (51.9) 13 (12.3) 1 (25.0) 24 (23.8) 77 (83.7) 58 (89.2) 41 (93.2) <0.001
Pfeiffer (Range 0–10),
mean (SD) 3.76 (3.33) 1.15 (0.15) 2.75 (1.80) 1.94 (0.20) 4.93 (0.23) 5.84 (0.36) 8.86 (0.39) <0.001
Emotional Status
Treatment for depression 158 (38.3) 34 (32.1) 2 (50.0) 48 (47.5) 35 (38.0) 20 (30.8) 19 (43.2) 0.117
Treatment for
anxiety/insomnia 226 (54.9) 53 (50.0) 1 (25.0) 74 (73.3) 45 (48.9) 25 (38.5) 28 (63.6) <0.001
Social Vulnerability
Presence of social
vulnerability 212 (51.5) 83 (78.3) 1 (25.0) 44 (43.6) 36 (39.1) 35 (53.8) 13 (29.5) <0.001
Living alone 70 (17.0) 43 (40.6) 0 (0.0) 15 (14.9) 6 (6.5) 5 (7.7) 1 (2.3) <0.001
Professional caregiver




Barthel Index, mean (SD) 48.4 (26.9) 73.0 (1.4) 35.0 (5.4) 51.1(1.7) 51.4 (1.8) 28.2 (3.3) 7.9 (2.1) <0.001
BI ≥ 95 No dependency 6 (1.5) 4 (3.8) 0 (0.0) 0 (0.0) 1 (1.1) 1 (1.5) 0 (0.0)
<0.001 (**)BI 90–65 (Mild–moderate) 143 (34.7) 85 (80.2) 0 (0.0) 26 (25.7) 22 (23.9) 9 (13.8) 1 (2.3)BI 60–25
(Moderate–severe) 175 (42.5) 16 (15.1) 4 (100.0) 71 (70.3) 67 (72.8) 15 (23.1) 2 (4.5)
BI ≤ 20 Absolute




Money management 350 (85.0) 50 (47.2) 3 (75.0) 97 (96.0) 91 (98.9) 65 (100.0) 44 (100.0) <0.001
Telephone use 132 (32.0) 0 (0.0) 0 (0.0) 10 (9.9) 26 (28.3) 52 (80.0) 44 (100.0) <0.001
Medication management 304 (73.8) 19 (17.9) 2 (50.0) 85 (84.2) 89 (96.7) 65 (100.0) 44 (100.0) <0.001
Frailty Frail-VIG
index (FI) Range 0–1
Frail VIG index, mean
(SD) 0.40 (0.12) 0.28 (0.01) 0.44 (0.02) 0.41 (0.01) 0.39 (0.01) 0.52 (0.01) 0.53 (0.01) <0.001
Non frailty (FI <0.20) 12 (2.9) 12 (11.3) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
<0.001
(***)
Mild frailty (FI 0.20–0.35) 116 (28.2) 68 (64.2) 0 (0.0) 23 (22.8) 24 (26.1) 1 (1.5) 0 (0.0)
Moderate frailty
(FI 0.36–0.50) 191 (46.4) 26 (24.5) 4 (100) 63 (62.4) 58 (63.0) 28 (43.1) 12 (27.3)





0.30 (0.23) 0.44 (0.18) 0.29 (0.16) 0.29 (0.21) 0.31 (0.24) 0.19 (0.24) 0.08 (0.01) <0.001
Mortality Mortality of 12 months 128 (31.1) 14 (13.2) 4 (100.0) 30 (29.7) 27 (29.3) 34 (52.3) 19 (43.2) <0.001Mortality of 24 months 190 (46.1) 31 (29.2) 4 (100.0) 44 (43.6) 40 (43.5) 45 (69.2) 26 (59.1) <0.001
(*) Profile 2 (4 cases) has been excluded in all p-value analyzes, in order to adjust to the application requirements of the tests. (**) The values
of the Barthel index have been grouped into three levels (BI ≥ 95; BI 90–25; BI ≤ 20), to adapt the criteria for applying the chi-square test.
(***) The frail-VIG index values have been grouped into three degrees of frailty (FI ≤ 0.35; FI 0.36–0.50; FI > 0.50) to adapt the criteria for
applying the chi-square test. NA. The p-value calculation requirements do not apply. Abbreviations: BI, Barthel Index; FI, Frail-VIG Index;
GFR, Glomerular Filtration Rate; SD, Standard Deviation.
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Comparing the three, six and nine cluster groups, the six-cluster group was found
to be the most parsimonious and clinically valuable. Tables 1 and 2 summarize the main
characteristics of the six profiles identified, ordered by degree of frailty.
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Quality of life 
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requirements do not apply. Abbreviations: BI, Barthel Index; FI, Frail-VIG Index; GFR, Glomerular Filtration Rate; SD, 
Standard Deviation. 
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characteristics of the six profiles identified, ordered by degree of frailty. 
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Severe frailty Severe frailty 
Age (years) 87.7 83.8 86.1 92.7 87.9 84.4 
Women (%) 76.4 50 56.4 84.8 46.1 77.3 
Chronic diseases 
and severe symptoms (0–6) 
2 3.6 3.2 1.7 2.6 1.4 
Physical frailty (0–4) (malnutrition, 
falls, ulcers, dysphagia) 
0.6 1.6 0.5 0.7 1.5 1.4 
Psychological frailty (0–5)  
(delirium, cognitive impairment, 
depression, anxiety/insomnia) 
0.9 1.6 1.5 2.3 2.2 3.4 
Social Frailty (0–1) 
(social vulnerability) 
0.8 0.3 0.4 0.4 0.5 0.3 
Functional dependence  
for ADL,s and IADL,s (0–6) 
1.8 3.3 3.7 4 5.2 5.9 
Frail-VIG index (0–1) 0.28 0.44 0.41 0.39 0.52 0.53 
The profiles are ordered according to the similarity between them. The darker the color, the higher frequencies or values 
of the variables. Frail-VIG index, higher scores represent a higher degree of frailty. Abbreviations: ADLs, Activities of 
Daily Living; IADLs, Instrumental Activities of Daily Living. 
Profile 1 (25.7%). Mainly women with mild frailty, social vulnerability, moderate 
multimorbidity and dependence for activities of daily living. This was the most numerous 
profile. The mean age of participants in this profile was 87.7 and they were primarily fe-
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(needs help)  
Medication m nagement 304 (73.8) 19 (17.9) 2 (50.0) 85 (84.2) 8  (96.7) 65 (100.0) 44 (100.0) <0.001 
Frailty 
Frail-VIG index 
(FI) Range 0–1 
Frail VIG index, mean (SD) 0.4  (0.12) 0.28 (0.01) 0.44 (0.02) 0.41 (0.01) 0.39 (0.01) 0.52 (0.01) 0.53 (0.01) <0.001 
Non frailty (FI <0.20) 1  (2.9) 12 (11.3)  (0.0)  (0.0)  (0.0)  (0.0)  (0.0) 
<0.001  
(***) 
Mild frailty (FI 0.2 –0.35) 116 (28.2) 68 (64.2)  (0.0) 23 (22.8) 24 (26.1)  (1.5)  (0.0) 
Moderate frailty (FI 0.36–0.50) 91 (46.4) 26 (24.5) 4 (100) 63 (62.4) 58 (63.0) 28 (43.1) 1  (27.3) 
S vere frailty (FI >0.50) 93 (22.6)  (0.0)  (0.0) 15 (14.9) 10 (10.9) 36 (55.4) 32 (72.7) 
Quality o  life 
EQ-5D-3L Index. (Range 0–1) 
mean (SD) 
0.3  (0.23) 0.44 (0.18) 0.29 (0.16) 0.29 (0.21) 0.31 (0.24) 0.19 (0.24) 0.08 (0.01) <0.001 
Mortality 
Mortality of 12 months 128 (31.1) 14 (13.2) 4 (100.0) 30 (29.7) 27 (29.3) 34 (52.3) 19 (43.2) <0.001 
Mortality of 24 months 190 (46.1) 31 (29.2) 4 (100.0) 4  (43.6) 40 (43.5) 45 (69.2) 26 (59.1) <0.001 
(*) Profile 2 (4 cases) has been exclu ed in all p-value nalyzes, in order to adjust to the application requirements of the 
tests. (**) The values of the Barthel index have been grouped into thre  l vels (BI ≥ 95; BI 90–25; BI ≤ 20), to dapt the 
criteria for applying the chi-squar  test. (***) The frail-VIG index values have been grouped into three degrees of frailty 
(FI ≤ 0.35; FI 0.36–0.50; FI > 0.50) to dapt the criteria for applying the chi-square test. NA. The p-value calculation 
requirements do not apply. Abbrev ations: BI, Barthel Index; FI, Frail-VIG Index; GFR, Glomerular Filtration Rate; SD, 
Standard Dev ation. 
Comparing the three, six and ine cluster groups, the six-cluster group was found to 
be the most parsimonious and cl nically valuable. Tables 1 and 2 su marize the main 
ch racter stics of the six profiles identified, ord red by degree of frailty. 
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S vere frailty S vere frailty 
Age (years) 87.7 83.8 86.1 92.7 87.9 84.4 
Women (%) 76.4 50 56.4 84.8 46.1 77.3 
Chronic diseases 
and s vere symptoms (0–6) 
2 3.6 3.2 1.7 2.6 1.4 
Physical frailty (0–4) (malnu rition, 
falls, ulcers, dysphagia) 
0.6 1.6 0.5 0.7 1.5 1.4 
Psychological frailty (0–5)  
(delirium, cognitive impairment, 
depression, anxiety/insomnia) 
0.9 1.6 1.5 2.3 2.2 3.4 
Social Frailty (0–1) 
(social vulnerability) 
0.8 0.3 0.4 0.4 0.5 0.3 
Functional d pendence  
for ADL,s and IADL,s (0–6) 
1.8 3.3 3.7 4 5.2 5.9 
Frail-VIG index (0–1) 0.28 0.44 0.41 0.39 0.52 0.53 
The profiles are ordered according o the similarity between them. The darker the color, the highe  frequencies or values 
of the v riables. Frail-VIG index, higher scores repr sent a higher degree of frailty. Abbrev ations: ADLs, Activities of 
Daily Living; IADLs, Instrumental Activities of Daily Living. 
Profile 1 (25.7%). Mainly women with mild frailty, social vulnerability, moderate 
multimorb dity an  d pendence for act vities of daily l ving. This was the most numerous 
profile. The mean age of participants in this profile was 87.7 and they w re primarily fe-
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V riables Total 
n = 412
Profile 1 
n = 106 
Profile 2 
n = 4 
Profile 3 
n = 01 
Profile 4 
n = 92 
Profile 5 
n = 65 
Profile 6 




(ne ds help)  
Medicatio  m nagement 304 (73.8) 1  (17.9) 2 (50.0) 85 (84.2) 8  (9 .7) 65 (1 0.0) 44 (1 0. ) < .001 
Frailty 
Frail-VIG index 
(FI) Range 0–1 
Frail VIG ind x, mean (SD) .4  ( .12) .28 ( .01) .44 ( .02) .4  ( .01) .39 ( .01) .52 ( .01) .53 (0.01) < .001 
Non frailty (FI < .20) 1 (2.9) 2 (11.3) (0.0) (0.0) (0.0) (0.0) (0.0) 
< .001  
(***) 
Mild frailty (FI 2 –0.35) 116 ( 8.2) 68 (64.2) (0.0) 3 (22.8) 24 (26. ) (1.5) (0.0) 
Mode te frailty (FI 36– .50) 91 ( 6.4) 26 (24.5) 4 (100) 63 (62.4) 58 (63.0) 28 (43.1) 1  (27.3) 
S vere frailty (FI > .50) 93 (22.6) (0.0) (0.0) 15 (14.9) 10 (10.9) 36 (55.4) 32 ( 2.7) 
Quality o  life 
EQ-5D-3L Index. (Range 0–1) 
mean (SD) 
.3  ( .23) .44 ( .18) .29 ( .16) . 9 ( .2 ) .31 ( .24) .19 ( .24) . 8 (0.01) < .001 
Mortality 
Mortality of 12 months 128 (3 .1) 14 (13.2) 4 (1 0. ) 30 (29. ) 27 (29.3) 34 (52.3) 19 (43.2) < .001 
Mortality of 24 months 190 (46. ) 31 ( 9.2) 4 (1 0.0) 4  (43.6) 40 (43. ) 45 (69.2) 26 (59.1) < .001 
(*) Profile 2 (4 case ) has been exclu ed in all p-v lue nalyzes, in order to adjust o the application quiremen s of the 
ests. (**) The values of the Barthel index have been grouped in o thre  l vels (BI ≥ 95; BI 90–25; BI ≤ 20), to dapt the 
criteri  for applying the chi-squar  est. (***) The frail-VIG index values have been grouped in o three degrees of frailty 
(FI ≤ 0.35; FI 36– .50; FI > .50) to dapt th  criteria for applying the chi-squar est NA. The p-value lculation 
quirements do not apply. Abbrev ations: BI, Barthel Index; FI, Frail-VIG Index; GFR, Glomerula  F l ration Rate; SD, 
Standard Dev ation. 
Comparing th  three, six and ine cluster groups, the six-cluster group was found to 
be the most parsimonious and linically va uable. Tables 1 and 2 su marize the main 
ch rac er stics of the six profil s identifie , or ered by d gree of frailty. 
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S vere frailty S vere frailty 
Age (years) 87.7 3.8 86.1 92.7 87.9 84.4 
Women (%) 76.4 50 56.4 4.8 46.1 77.3 
Chronic di eases 
and s vere sy ptoms (0–6) 
2 3.6 3.2 1.7 2.6 1.4 
Physical frailty (0–4) (malnutrition, 
falls, ulcer , dysphagia) 
0.6 1.6 0.5 0.7 1.5 1.4 
Psychological frailty (0–5)  
(delirium, cogn tive mpairment, 
depression, anxiety/insomnia) 
0.9 1.6 1.5 2.3 2.2 3.4 
Socia  Frailty (0–1) 
(social vulnerability) 
0.8 0.3 0.4 0.4 0.5 0.3 
Fu ctional d pendence  
for ADL,s and IADL,s (0–6) 
1.8 3.3 3.7 4 5.2 5.9 
Frail-VIG index (0–1) 0.28 0.44 0.41 0.39 0.52 0.53 
The profil s ar  ordered according o the s milari y b twe n them. The darker the color, t e higher frequencies or values 
of the v riables. Frail-VIG index, highe  cores r present a higher degree of frailty. Abbrev ations: ADLs, Activities of 
Daily Living; IADLs, Instrumental Activities of Daily Living. 
Profile 1 (25 7%). Mainly women with mild frailty, social vulnerability, moderate 
multimorbidity and d pendence for activities of dai y living. Thi was the most numerous 
profile. The mean age of participa ts n this profile was 87.7 and th y were p marily fe-




















(needs help)  
Med cation management 04 (73.8) 9 (17.9) 2 (50.0) 5 (84.2) 89 (96.7) 65 (1 0.0) 4 (1 0.0) <0. 01 
Frailty 
Frail-VIG index 
(FI) Range 0–1 
Frail VIG index, mean (SD) 0.40 (0.12) 0.28 (0. 1) 0. 4 (0. 2) 0.41 (0. 1) 0.39 (0. 1) 0.52 (0. 1) 0.53 (0. 1) <0. 01 
Non frailty (FI <0.20) 12 (2.9) 2 ( 1.3) 0 (0.0) 0 (0.0) 0 (0. ) 0 (0.0) 0 (0.0) 
<0. 01  
( *) 
M d frailty (FI 0.20–0.35) 16 (2 .2) 8 (64.2) 0 (0.0) 3 ( .8) 4 (26.1) 1 (1.5) 0 (0.0) 
Mod rate frailty (FI 0.36–0.50) 191 (4 .4) 6 (24.5) 4 (1 0) 3 (62.4) 58 (63.0) 28 (43.1) 12 (27.3) 
Severe frailty (FI >0.50) 93 ( 2.6) 0 (0. ) 0 (0.0) 5 (14.9) (10.9) 36 ( 5.4) 3 (72.7) 
Quality of life 
EQ 5D-3L Index. (Range 0–1) 
mean (SD) 
0. 0 (0.23) 0. 4 (0.18) 0.29 (0.16) 0.29 (0.21) 0.31 (0.24) 0.19 (0.24) 0. 8 (0. 1) <0. 01 
Mortality 
Mortality of 12 months 28 (31. ) 4 (13.2) 4 (1 0.0) 30 (29.7) 7 (29.3) 34 (52.3) 19 (43.2) <0. 01 
Mortality of 24 months 190 (46.1) 31 (29.2) 4 (1 0.0) 4 (43.6) 0 (43.5) 45 (69.2) 26 (59.1) <0. 01 
(*) Profile 2 (4 cases) has b en excluded in ll p-value analyzes, in o der to adjust to the pl cation requirements of the 
tests. ( *) Th  values of the Barth l index have b en grouped into thr e levels (BI ≥ 95; BI 90–25; BI ≤ 20), to adapt the 
c iteria for a plying t e chi-square test. ( *) The frail-VIG index values have b en grouped into thr  degr es of frailty 
(FI ≤ 0.35; FI 0.36–0.50; FI > 0.50) to adapt the c iteri  for a plying the chi-square test. NA. The p-v ue calculation 
requirements d  not a ply. A breviations: I, Barth l Index; I, Frail-VIG Index; FR, Glomerular Filtration Rate; SD, 
St n ard Deviation. 
Comparing t  thr e, six a d nine cluster group , the six-cluster group was found to 
be the most pars m nious a d c inically v luable. Tables 1 and 2 summarize the main 
haracteri tics of the six profiles id ntified, o dere  by d gr e of frailty. 
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Severe frailty Severe frailty 
Ag  (years) 87.7 83.8 86.1 92.7 87.9 84.4 
Women (%) 76.4 50 56.4 84.8 46.1 7.3 
Chron c diseases 
and severe symptoms (0–6) 
2 3.6 3.2 1.7 2.6 1.4 
Physic l frailty (0–4) (malnutrition, 
falls, ulcers, dysphagia) 
0.6 1.6 0.5 0.7 1.5 1.4 
Psycho ogic l frailty (0–5)  
(delirium, cognit ve i pairment, 
d pre sio , anxiety/insomnia) 
0.9 1.6 1.5 2.3 2.2 3.4 
Social Frailty (0–1) 
(social vulnerability) 
0.8 0.3 0.4 0.4 0.5 0.3 
Functional p d nce  
for ADL,s and IADL,s (0–6) 
1.8 3.3 3.7 4 5.2 5.9 
Frail-VIG index (0–1) 0.28 0. 4 0.41 0.39 0.52 0.53 
The profiles a e o dered a cording to the s milarity b tw en them. Th  darker the color, t  igher fr quencies or values 
of the variables. Frail-VIG index, igher sco s represent a igher degr e of frailty. A breviations: ADLs, Activities of 
Daily Living; IADLs, Instrumen al Activities of Daily Living. 
Profile 1 (25.7%). Mainly women w th mild frailty, social vulnerability, moderate 
ultimorbidity and depend nce for ac vities of da ly living. This was the most numerous 
profile. The me n age of participants in this profile was 87.7 and they were primarily fe-




















(needs help)  
Medication ag ment 04 (73.8) 9 (17.9) 2 (50.0) 5 (84.2) 8 (96.7) 65 (100.0) 44 (1 . ) <0.001 
Frailty 
Frail-VIG index 
(FI) Range 0–1 
Frail VIG index, mean (SD) 0.4 (0.12) 0.28 (0.01) 0.44 (0.02) 0.41 (0.01) 0.39 (0.01) 0.52 (0.01) 0.53 (0. 1) <0.001 
Non frailty (FI <0.20) 1  (2.9) 2 (11.3)  ( .0)  ( .0)  ( .0)  ( .0)  (0.0) 
<0.001  
(***) 
M d frailty (FI 0.2 –0.35) 116 (28.2) 8 (64.2)  (0.0) 3 (2 .8) 4 (26.1)  (1.5)  ( . ) 
Moderate frailty (FI .36–0.50) 91 (46. ) 6 (24.5) 4 (100) 3 (62.4) 58 (63.0) 28 (43.1) 1 (27.3) 
S v e frailty (FI >0.50) 93 (22.6)  ( .0)  (0.0) 5 (14.9) (10.9) 36 (55.4) 3 (72.7) 
Quality of life 
EQ-5D-3L Index. (Range 0–1) 
mean (SD) 
0.3 (0.23) 0.44 (0.18) 0.29 (0.16) 0.29 (0.21) 0.31 (0.24) 0.19 (0.24) 0. 8 (0. 1) <0.001 
Mor ality 
M r ality of 12 months 28 (31. ) 4 (13.2) 4 (1 0.0) 30 (29.7) 7 (29.3) 34 (52.3) 19 (43.2) <0.001 
M r ality of 24 months 190 (46.1) 31 (29.2) 4 (100.0) (43.6) 0 (43.5) 45 ( 9.2) 26 (59.1) <0.001 
(*) Profile 2 (4 ca es) has be n exclu ed in all p-valu  nalyzes, in o der to adjust to the pplicat on r quir ments of the 
tests. (**) The values of the Barth l index hav  been grouped into thr  l vels ( ≥ 95; BI 90– 5; BI ≤ 20), to dapt the 
c teria for applying the chi-squar  test. (***) The frail-VIG index values hav  been grouped into thr d g ees of frailty 
(FI ≤ 5; FI .36–0.50; FI > 0.50) to dap  the c te i  for applying the chi-square test. NA. Th p-v lue calculation 
r quir men s d  not apply. Abbreviations: I, Barth l ndex; I, Frail-V G Index; FR, Glomerular Filtration Rate; SD, 
Stan ard Deviation. 
Comparing th  three, six a d ine cluste  groups, the six-cluste  group was found to 
be the most pars m ious and c nical y v luable. Tables 1 and 2 su marize the main 
h racteristics of the six profiles ntifi d, ord r by d gree of frailty. 
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S v e frailty S v e frailty 
Age (years) 87.7 83.8 86.1 92.7 87.9 84.4 
Women (%) 76.4 50 56.4 84.8 46.1 77.3 
Chronic di a es 
and s v re sy ptoms (0–6) 
2 3.6 3.2 1.7 2.6 1.4 
Physical frailty (0–4) (malnu rition, 
falls, ulcers, dysph gia) 
0.6 1.6 0.5 0.7 1.5 1.4 
Psych ogical frailty (0–5)  
(delirium, cognitive i pairment, 
d pressio , anxiety/i somnia) 
0.9 1.6 1.5 2.3 2.2 3.4 
Social Frailty (0–1) 
(social vulnerability) 
0.8 0.3 0.4 0.4 0.5 0.3 
Functio al pend nce  
for ADL,s and IADL,s (0–6) 
1.8 3.3 3.7 4 5.2 5.9 
Frail-VIG index (0–1) 0.28 0.44 0.41 0.39 0.52 0.53 
The profiles are o d ed acc rding to the s m larity betw en them. The da ker the c lor, t  igh  frequencies or values 
of the vari bles. Frail-VIG nd x, igher scores pr sent a igh r d gree of frailty. Abbreviations: ADLs, Ac vities of 
Daily Living; IADLs, I strumen al Ac vities of Daily Living. 
Profile 1 (25.7%). Mainly women with mild frailty, social vulnerability, moderate 
ultimorb dity an  dep ndence for act vities of daily l ving. This was the ost numerous 
profil . The me n age of participants in this profile w s 8 .7 and they w re primarily fe-
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Variables Total   412 
r fil  1 
n = 106
r fil  2 
n = 4
r file 3 
n = 01
r fil  4 
  92
r fil  5 
  65
Profi e 6 
n = 44 
p-Value 
(*) 
Daily L ving 
(ne ds help)  
Medic tio  a agement 304 73.8  1  17.9 2 (5 .0) 85 (84.2) 89 9 .7) 65 ( . ) 44 (1 0. ) < .001 
Frailty 
Frail-VIG index 
(FI) Range 0–1 
Frail VIG i d x, mean (SD) 4  ( 1 ) 28 ( 1) 0 44 ( 02) 0 4  ( 01) 39 ( ) 0 52 ( 01) 53 ( 1) < .001 
Non frailty (FI <0.20)  .9) 12 (11.3)  ( .0)  ( .0)  ( . )  ( .0)  ( .0) 
< .001  
( **) 
Mild frailty (FI 2 –0.35) 116 28.  68 (64.2)  ( .0) 23 (22.8) 24 (26. ) 1 (1.5)  ( .0)
Mod te frailty (FI 36–0.50) 91 46.4  26 24.5) 4 (100) 63 (62.4) 5  (6 .0) 28 (43. ) 12 (27.3
S v re frailty (FI >0.50) 93 (22.6)  ( . )  ( .0) 15 (14.9) 10 (10.9) 36 (55.4) 32 (72.7) 
Quality of life 
EQ-5D-3L Index. (Range 0–1) 
mean (SD) 
3  ( 23) 44 ( 18) 0 29 (0 16) 0 9 (0 2 ) 31 ( ) 0 19 (0 24) 8 ( 1) < .001 
Mortality 
M rtality of 12 months 28 3 .1  14 (13.2) 4 (1 . ) 30 (29. ) 27 (29. ) 34 (52.3) 19 (43.2) < .001 
M rtality of 24 months 90 46.1  31 (29.2) 4 (10 .0) 44 (43.6) 0 (43. ) 45 ( 9. ) 26 (59.1) < .001 
(*) Profile 2 (4 ca s) has b en exc uded in all p-value analyzes, in or er o adjus  to the application quiremen s of the 
te ts. (**) The valu s of the Bart el index hav  b en gr uped into thre evels (BI ≥ 9 ; I 90–25; BI ≤ 20), o adapt the 
crite i  for apply ng t e chi-square test. ( **) The frail-VIG index valu s hav  b en gr uped into thr  d grees of frailty 
( I ≤ 0.35; FI 36– . ; FI > 0.50) o adap th  criteria for applying t e chi-square test NA. The p-value c lculation 
quirements do not apply. Abbreviations: B , Barthel Index; FI, Frail-VIG Index; GFR, Glome u a Fil ration Rate; SD, 
St ndard Deviation. 
Comparing  three, six and ine cl ster groups, the six-cl ster group was found to 
b  the most par imonious and clinic lly valu . Tables 1 and 2 su mariz  the main 
ch a teristics of the six prof l s identifi , or re  by d g ee of frailty. 
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S v re frailty S v re frailty 
Age (years) 8 .7 83.8 86.1 92.7 87.9 8 .4 
Women (%) 76.4 50 56.4 84.8 46.1 77.3 
Chronic di ea es 
and s v re sy ptoms (0–6) 
2 3.6 3.2 1.7 2.6 1.4 
Physic l frailty (0–4) (mal utrition, 
fal s, ulcers, dysphagia) 
0.6 1.6 0.5 0.7 1.5 1.4 
Psych logic l frailty (0–5)  
(delirium, cogn tiv  mpairment, 
depress on, a xiety/i somnia) 
0.9 1.6 1.5 2.3 .2 3.4 
Soci  Frailty (0–1) 
(social vulnerability) 
0.8 0.3 0.4 0.4 0.5 0.3 
Fu ctional depe dence  
for ADL,s and IADL,s (0–6) 
1.8 .3 3.7 4 5.2 5.9 
Frail-VIG index (0–1) 0.28 0.44 0.41 0.39 0.52 0.53 
The p ofil s ar  or red acc rding to the similari y b twe n them. The darker t  c lor, th  high r fr qu ncies or values 
of the var ab es. Frail-VIG ind x, highe  cores r pr s nt a hi h d gree of frailty. Abbreviations: ADLs, Act vities of 
Daily L ving; ADL , Instrumental Act v ties of Daily L ving. 
Profile 1 (25.7%). Mainly women with mild frai ty, soci l vu nerability, mod rate 
multimorbi ity an  dep d n e for act vities of da ly l v ng. Thi  was the most n merous 
profil . Th  mean age of par cipa t n this profile w s 8 .7 and th y w e p marily fe-
Degree of frailty Mild frailty Moderate frailty Moderate frailty Moderate frailty Severe frailty Severe frailty
Age (years) 87.7 83.8 86.1 92.7 87.9 84.4




2 3.6 3.2 1.7 2.6 1.4
Physical frailty (0–4)
(malnutrition, falls,
ulcers, d sph gi




impa rm t, d pression,
anxiety/insomnia)
0.9 1.6 1.5 2.3 2.2 3.4
Social Frailty (0–1)
(social vulnerability) 0.8 0.3 0.4 0.4 0.5 0.3
Funct on depend nce
for ADL,s and IADL,s
(0–6)
1.8 3.3 3.7 4 5.2 5.9
Frail-VIG index (0–1) 0.28 0.44 0.41 0.39 0.52 0.53
The profiles are ordered according to the similarity between them. The darker the color, the higher frequencies or values of the variables.
Frail-VIG ind x, high r sc res represent a higher degree of frailty. Abbreviations: ADLs, Activities of Daily Living; IADL , Instrumental
Activities of Daily Living.
Profile 1 (25.7%). Mainly women with mild frailty, social vulnerability, moderate
multimorbidity and dependence for activities of daily living. This was the most numerous
pr file. The mean age of participa ts i this profile w s 87.7 and they w re pri arily female
(76.4%). It was the o ly profile with mil fr ilt and t e one wit t e lowe t p evalence
f cog itiv im airment (12.3%). H wev r, we highlig te social vulnerabilit among
the majority (78.3%) and the higher percentage of cases living alone (40.6%) compared to
the other profiles. 28.3% of the cases had three or more chronic diseases in target organs,
the most prevalent being cardiac (55.7%) and renal (52.8%). This profile had the least
dependence in regard to ADLs and IADLs (moderate-low) and the least accumulation
of geriatric syndromes, with falls (25.5%) and chronic wounds (9.4%) being significant.
Mortality at one year (13.2%) was the lowest of the six profiles identified.
Profile 2 (1.0%). People with moderate frailty affected by advanced cancer. This was
the least numerous profile, as it only applies to four participants. Nevertheless, we decided
to include it because of its clinical significance. The mean age was 83.8, and half were
women. The participants were moderately dependent in regard to ADLs and IADLs. This
group had the lowest social vulnerability, and all participants lived with someone. The
degree of frailty was moderate, with a FI of 0.44. Mortality at one year was 100%.
Profile 3 (24.5%). Mainly people with moderate frailty, moderate dependence, cardiac
disease and high multimorbidity. This was the second most numerous profile. The mean
age was 86.1 and 56.4% of cases were women. The main characteristic of this profile was
the high level of multimorbidity: half of the people had three or more chronic diseases in
target organs, with the highest proportions in heart disease (84.2%), kidney disease (55.4%),
respiratory disease (47.5%) and neurological disease (47.5%). It also had the highest rate of
advanced chronic disease (17.8%). There was mild cognitive impairment among 23.8% of
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cases, and moderate-high dependence for ADLs and IADLs. 43.6% of cases were socially
vulnerable, and 14.9% lived alone. A quarter of the participants had experienced falls and
12.9% had chronic wounds. The degree of frailty for this profile was moderate (FI 0.41).
Mortality at one year was 29.7%.
Profile 4 (22.3%). Primarily nonagenarian women with moderate frailty, mild cognitive
impairment and moderate-high dependence. This was one of the most numerous profiles,
the oldest (a mean age of 92.7) and mainly women (84.8%). It was characterized by the high
presence of mild cognitive impairment (83.7%) and moderate-high dependence for ADLs
and IADLs. Social vulnerability was present in 39.1% of cases, with 6.5% living alone and
29.3% with a 24-h informal caregiver. 16.3% of the cases had three or more chronic diseases
in target organs, the most prevalent being kidney (62.0%) and renal (40.2%) diseases. 21.7%
of cases had three or more geriatric syndromes, with rates of delirium at 46.7%, falls 35.9%
and ulcers 22.8%. All this implied a moderate degree of frailty (FI 0.39). Mortality at one
year was 29.3%.
Profile 5 (15.8%). Mainly men with severe frailty, moderate-high multimorbidity and
high dependence. The mean age under this profile was 87.9, and a minority were women
(46.1%). They had a high proportion of moderate cognitive impairment (89.2%), and severe
dependence for ADLs and IADLs. This was the second most socially vulnerable profile,
at 53.8%. 7.7% of the people in this profile lived alone and 27.7% lived with an informal
caregiver. 46.2% of cases had three or more chronic diseases in target organs, the most
prevalent being cardiac (78.5%), neurological (61.5%) and renal (46.2%) diseases. Half of
the people had three or more geriatric syndromes, with 56.9% having delirium. This profile
had the highest proportion of falls (36.9%) and chronic wounds (36.9%). All of the above
reflected a degree of severe frailty (FI 0.52). Mortality at one year was 52.3%.
Profile 6 (10.7%). Mainly women with severe frailty, cognitive impairment, dyspha-
gia and total dependence. The cases in this profile were mainly women (77.3%), with a
mean age of 84.4 years. We found the highest rate-93.2%-of cognitive impairment (moder-
ate/severe) and total dependence for ADLs and IADLs. Social vulnerability was indicated
in 29.5% of cases, and it was the profile with the highest percentage of permanent informal
caregivers at 31.8%. This profile had the lowest burden of overall multimorbidity, with a
predominance of neurological disease (52.3%) as well as over half the cases having three or
more geriatric syndromes, with higher rates than under the other profiles for dysphagia
(75%) and delirium (63.6%). Chronic wounds were also present in a third of cases. All of
the above implied severe frailty (FI 0.53). Mortality at one year was 43.2%.
4. Discussion
The aim of the study was to identify frailty profiles among older people users of a
home-based primary care service from a multidimensional perspective (physical, psycho-
logical and social). We identified six frailty profiles. Three of these profiles corresponded to
a moderate frailty degree, two to a severe frailty degree and one to a mild frailty degree. In
addition, almost three quarters of the study population were clustered into three profiles
(profiles 1, 3 and 4) that corresponded to mild and moderate degree of frailty. It is they,
therefore, who could benefit from planning frailty-prevention activities.
The profiles identified reveal underlying problems among the different domains of
frailty and interrelated concepts (morbidity and dependence). These confirm the complexity
of frailty, which is not sufficiently captured from measuring the degree of frailty and the
distinction between the different domains affected (physical, psychological and social).
These results are in line with three previous studies that looked at profiles of peo-
ple living in the community using a multidimensional assessment approach. Lafortune
et al. [14] identify four profiles based on the assessment of physical and cognitive dimen-
sions: relatively healthy, physical-cognitive impairment, significant physical impairment
and significant cognitive impairment. Armstrong et al. [15] identify seven profiles among
home-based rehabilitation clients, based on an assessment of physical, cognitive and social
dimensions: people living alone and requiring assistance with housework and bathing;
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cognitively intact people who are independent in regard to ADLs; people requiring assis-
tance with IADLs and bathing; women requiring assistance with IADLs; women requiring
assistance with IADLs and some ADLs; people who are dependent but mobile and have
cognitive problems; people who are dependent and immobile with cognitive problems.
Looman et al. [16] identify six profiles based on physical, cognitive, and social functioning:
relatively healthy; mild physical frailty; psychological frailty; severe physical frailty; med-
ically frail; and multi-frail. All three studies identify a profile of relatively healthy older
people, which did not appear in the present study. This could be related to the fact that
the study population was composed of people included under a home-care program, who
present greater vulnerability. In another recent study [32], three functional groups of older
people at risk of disability are identified: physical, social and mixed. The psychosocial
group, however, includes variables from the psychological and social dimensions, which
can make it difficult to plan differentiated preventive or management activities.
The vast majority of frailty research that focuses on people’s outcomes is based on
adverse outcomes, such as mortality, dependence, hospitalization and institutionalization.
Outcomes related to positive aspects such as well-being and quality of life are less stud-
ied [24,33]. In our study, we have analyzed both negative outcomes (mortality, dependence,
polypharmacy) as well as a positive outcome (quality of life). Frail older people can also
present improvement in their quality of life. Therefore, the information will also serve to
personalize the care plans based on a positive approach.
The main strength of this study is the statistical technique applied to determine the
profiles, as well as the standardized data collection, using simple measurement instruments
that are commonly used in healthcare practice. This pragmatic perspective would be
feasible and capable of being extrapolated to larger populations. Another strong point is
the differentiation between the concepts of frailty, morbidity and dependence, as it helps
with planning care that is better aligned with needs. Where there is morbidity, activities
will be planned to prevent or reduce frailty; where there is frailty, activities will be planned
to prevent adverse outcomes, such as dependence [21].
4.1. Limitations and Future Research Recommendations
The main limitation of the study is that although the sample studied was large and
all possible participants have been included, it corresponds to an aging population in an
urban area with a medium-high socio-economic level, which makes it difficult to generalize
the results to other settings or populations. Moreover, the Frail-VIG index is a simple and
feasible instrument for use in the care setting, albeit with some limitations: the variables that
correspond to physical frailty are focused on geriatric syndromes (weight loss, dysphagia,
falls, ulcers) and do not include other variables that are recognized for identifying physical
frailty. Here, the reference model would be Fried’s phenotype [9].
Future studies should contrast the results obtained in relation to other populations
included under home-care programs with different socio-cultural levels and analyze other
environments (for example, residential). It would also be useful to assess aspects of social
frailty in greater depth. We suggest that this should include the three main components
identified in a recent review: threat or absence of social resources to meet basic social
needs; threat or absence of social behaviors and social activities; and threat or absence of
self-management skills [34].
4.2. Care Implications and Outlook for the Future
The multidimensional nature of frailty has resulted in the identification of heteroge-
neous profiles, under which it would be useful to adapt care plans in health care practice.
The multidimensional impact of frailty justifies multicomponent interventions [35–37].
Indications for multimorbidity management should also take account of health priorities,
assess the potential benefits of interventions against potential harms, identify the person’s
health trajectory, and encourage shared decision making, aligning people’s wishes and
professionals’ opinions [1,38]. An effective overall management approach would include
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physical activity, nutritional supplementation, cognitive training, structured medication
review, and social reinforcement. This approach shares similarities with other programs
studied in our healthcare setting with the resources available in community care and other
devices in the territory [39–41]. Table A1 in appendix shows, as an example a pragmatic
proposal of care objectives and interventions for the different profiles identified, according
to the current evidence for the management of frailty [35–37] and the multimorbidity [1,38].
Finally, it would also be helpful to include the opinions of the people cared for at home,
their family members and caregivers on the profiles identified, as well as the care plans
proposed for each of them.
5. Conclusions
This study identified six profiles of frailty, with clinical interest in older people users of
a home-based primary care service. It shows that the population included under the home-
care program is heterogeneous and has different care needs. Identifying these profiles
complements information on degrees of frailty as it enables different care needs to be
ascertained for people who are identified as having the same degree of frailty and is useful
when designing interventions that are aligned with the needs of each population profile.
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A–B C B–A B–A C–B C–B 
(A) Survival 
(B) Preserve and enhance autonomy 
(C) Wellbeing and symptom control 
Physical activity planning 
Group  Individual  Group  Group  Individual  Individual  
activity personalised activity activity personalised personalised 
    
according to 
comorbidity 
      
Promote self-care ++ + +++ ++ − − 
Maintenance of autonomy +++ ++ +++ +++ + + 
Technical help/home adaptations + ++ + + ++ ++ 
Diet, and nutritional supplements 
Healthy diet 
Nutritional 
Diet Healthy diet Healthy diet/on demand 
supplements on demand Nutritional supplement Nutritional supplement 
  adapted to comorbidity adapted to comorbidity 
Prevention and management of dysphagia + ++ + + ++ +++ 
Cognitive stimulation + − + ++ ++ − 
Psychological intervention (Depres-
sion/Anxiety) 
++ +++ +++ ++ ++ − 
Prevention and management of delirium − + + ++ ++ +++ 
Therapeutic adequacy and deprescription + +++ + ++ +++ +++ 
Social intervention +++ +++ + + ++ ++ 
Palliative needs care + ++++ + + +++ +++ 
Advance care planning + ++++ ++ ++ +++ +++ 
Caregiver support + +++ ++ ++ +++ +++ 
Grief management in the patient’s family 
environment 
+ ++++ ++ ++ +++ +++ 
Degree of intensity of the proposed interventions: minimum intensity (−), mild intensity (+), moderate intensity (++), high 
intensity (+++), very high intensity (++++). 
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(C) Wellbeing and symptom control 
Physical activity pla ning 
Group  Individual  Group  Group  Individual  Individual  
activity personalised activity activity personalised personalised 
    
according to 
c morbidity 
      
Pr mot  self-care ++ + +++ ++ − − 
Mai tenance of aut nomy +++ ++ +++ +++ + + 
Technical help/home ad ptations + ++ + + ++ ++ 
Diet, a d nutritional suppl ments 
Healthy diet 
Nutritional 
Diet Healthy diet Healthy diet/on demand 
suppl ments on demand Nutritional suppl ment Nutritional suppl ment 
  adapted t  c morbidity adapted t  c morbidity 
Preventio  and manag ment of dysph gia + ++ + + ++ +++ 
Cognitive stimulation + − + ++ ++ − 
Psychological int rvention (Depres-
sion/Anxiety) 
++ +++ +++ ++ ++ − 
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P lliativ  needs care + ++++ + + +++ +++ 
Advan e care pla ning + ++++ ++ ++ +++ +++ 
Caregiver support + +++ ++ ++ +++ +++ 
Grief manag me t in the patient’s family 
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D gree of i tensity of the pr posed int rventions: mini um i tensity (−), mild i tensity (+), moderate i tensity (++), igh 
i tensity (+++), very igh i tensity (++++). 
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(A) Survival 
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(C) W llbeing and symptom control 
Physical ac ivity pla ning 
Group  In ividual  Group  Group  In ividual  In ividual  
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according to 
c morbidity 
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Prevention d management of dysphagia + ++ + + ++ +++ 
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(A) Survival 
(B) P eserve and hance autonomy 
(C) W llbei g and symptom c ntrol 
Physical ctivity planning 
Group  In ividual  Group  Group  In ividual  In ividual  
activity person lised activity activity personalised personalised 
    
according to 
comorbidity 
      
Promote self-care ++ + +++ ++ − − 
Mainten nce of autonomy +++ ++ +++ +++ + + 
T chnical help/home adaptations + ++ + + ++ ++ 
Diet, and utritional supplements 
Healthy diet 
Nutritional 
Diet Healthy diet Healthy iet/o  demand 
suppleme ts o  demand Nutritional supplement Nutritional supplement 
  adap ed to comorbi ity adap ed to comorbidity 
Preve tion and anagement of dysphagia + ++ + + ++ +++ 
Cognitive stimulation + − + ++ ++ − 
Psy holog cal i terve tion (Depres-
sio /Anxiety) 
++ +++ +++ ++ ++ − 
Preve tion and a ag m nt of delirium − + + ++ ++ +++ 
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Social i terve tion +++ +++ + + ++ ++ 
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Advance care planning + ++++ ++ ++ +++ +++ 
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environment 
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Priority Obj ctive 
A–B C B–A B–A C–B C–B 
(A) Survival 
(B) Pr serve and enh ce autonomy 
(C) Wellbeing and sy pt m control 
Phys cal activity pla ning 
Group  Individual  Group  Group  Individual  Individual  
activity p rsonalised activity activity p rsonalised p rsonalised 
  
a cording to 
comorbidity 
   
Promot  self-care + + + + − − 
Maintenance f autonomy + + + + + + 
Tec nical l /home adaptations + + + + + + 
Diet, and nutr tional su plements 
H althy diet 
Nutr tional 
Diet H althy diet H althy diet/on demand 
su plem nts on demand Nutr tional su plemen  Nutr tional su plement 
  adapted to comorbidity adapted to comorbidity 
Prevention nd management of dysphagia + + + + + + 
Cogn tive stimulation + − + + + − 
Psychological intervention (Depres-
sion/Anxiety) 
+ + + + + − 
Prevention nd management of delirium − + + + + + 
Therapeuti  a equacy and deprescription + + + + + + 
Social intervention + + + + + + 
Palliative n eds care + + + + + + 
Adv ce care pla ning + + + + + + 
Caregiver su port + + + + + + 
Grief ma ag m nt in the p tient’s family 
e vironment 
+ + + + + + 
Degr e  intensi y of th  proposed interventions: imum intensity (−), mild intensity (+), moderate intensity ( +), high 
intensity ( +), v ry high intensity ( +). 
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Physic l ac vity pla ing 
Group  In ividual  r   Group  In ivi ual  In ividual  
ac ivity personal sed c i i  ac ivity personalised personalised 
    
according to 
c morbidity 
      
P mot  self-care ++   ++ − − 
M i te ce of aut nomy ++   +  + + 
Technic  help/home d ptations + +   + +  ++ 
D et, a d tritio al supplements 
Healthy diet 
Nutritional 
Diet Healthy diet Healthy di t/o  demand 
suppleme ts o  demand N tritio al supplement N tritio al supplement 
  dapted to c morbi ity dapted to c morbidity 
Pr ve tion a d nagement of dysphagia + +   + ++ ++ 
Cognitive stimulation + −  +  ++ − 
Psy hological int ve tion (D pres-
sio /Anxiety) 
++   +  ++ − 
Pr ve tion a d nag m nt of delirium −   +  ++ ++ 
Ther peutic a equa y an  d prescription  +  ++  ++ 
Social int rve tion  +  + +  ++ 
Palliativ ne ds care + +    ++ 
Advance care pla ing + +  ++  ++ 
Ca egiver support    ++  ++ 
Grief agem  i  the patient’s family 
environment 
+ +  ++  ++ 
D gree of i t nsity f the r posed int rve t ons: ini um i tensity (−), mild i tensi y (+), mod rate i tensity (++), igh 
i t nsit ( ++), very igh i tensity ( ++). 
Prio ity Obj i
A–B C B–A B–A C–B C–B
(A) Survival
(B) Preserve and enhance
autonomy
(C) Wellbei g and
symptom control
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Table A1. Cont.
Profiles Profile 1 Profile 2 Profile 3 Profile 4 Profile 5 Profile 6
Physical activity planning
Group Individual Group Group Individual Individual
activity personalised activity activity personalised personalised
according to
comorbidity
Promote self-care ++ + +++ ++ − −
Maintenance of autonomy +++ ++ +++ +++ + +
Technical help/home




Nutritional Diet Healthy diet Healthy diet/on demand
supplements on demand Nutritional supplement Nutritional supplement
adapted to comorbidity adapted to comorbidity
Prevention and
management of dysphagia + ++ + + ++ +++
Cognitive stimulation + − + ++ ++ −
Psychological intervention
(Depression/Anxiety) ++ +++ +++ ++ ++ −
Prevention and
management of delirium − + + ++ ++ +++
Therapeutic adequacy and
deprescription + +++ + ++ +++ +++
Social intervention +++ +++ + + ++ ++
Palliative needs care + ++++ + + +++ +++
Advance care planning + ++++ ++ ++ +++ +++
Caregiver support + +++ ++ ++ +++ +++
Grief management in the
patient’s family
environment
+ ++++ ++ ++ +++ +++
Degree of intensity of the proposed interventions: minimum intensity (−), mild intensity (+), moderate intensity (++), high intensity (+++),
very high intensity (++++).
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